We're probing immune biology to deliver insights and identify your lead candidates
We've leveraged our cutting-edge technologies to build a ground-breaking platform for Immuno-oncology drug discovery. Our collection of high throughput assays allows you to rapidly identify single agents or combinations that effect T cell proliferation and polarization, tumor cell lysis, and natural killer (NK) cell function.
Gene-editing in immune cells for your immuno-oncology project is now even faster than before. Leveraging the latest genome engineering tools, including CRISPR-Cas9, we're able to precisely edit T-cell, B-cell, and monocytes lines.
Immuno-oncology is an area of research which investigates how a body’s own immune system can fight cancer.
Use our T cell proliferation and MLR assays to understand your compound’s effect on T cell activity, alone or in combination with a checkpoint inhibitor.
Our ADCC and CDC assays will measure your antibody’s efficacy in eliciting tumor cell killing responses. We have a bank of 800+ tumor cells to choose from.
Use our T cell-mediated tumor cell lysis assay to assess the activity of your Bispecific T Cell Engager (BiTE).